Janux Therapeutics
+$0.14 (+0.95%) As of 8:05 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.
About JANX
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.
CEO
David Campbell
Employees
—
Headquarters
La Jolla, California
Founded
2017
JANX Key Statistics
Market cap
620.01M
Price-Earnings ratio
—
Dividend yield
—
Average volume
95.95K
High today
$15.21
Low today
$14.63
Open price
$14.64
Volume
102.83K
52 Week high
$37.99
52 Week low
$14.08
JANX Earnings
-$0.62
-$0.41
-$0.21
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 24, After Hours